<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="100">
  <stage>Registered</stage>
  <submitdate>1/08/2005</submitdate>
  <approvaldate>1/08/2005</approvaldate>
  <actrnumber>ACTRN12605000061639</actrnumber>
  <trial_identification>
    <studytitle>Randomised controlled trial of maintenance fluids in paediatric intensive care.</studytitle>
    <scientifictitle>Randomised controlled trial of maintenance fluids in paediatric intensive care: effect on plasma sodium concentration.</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Children admitted to paediatric intensive care (PICU)</healthcondition>
    <conditioncode>
      <conditioncode1>Blood</conditioncode1>
      <conditioncode2>Haematological diseases</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Main study: randomised to either traditional maintenance fluid rate or 2/3 this rate as either 0.9% saline or 4% dextrose 0.18% saline for 12 to 24 hours (factorial design).
Secondary study: randomised to 2/3 traditional maintenance rate as either 0.9% saline or 4% dextrose 0.18% saline for 12 to 24 hours.</interventions>
    <comparator>4% dextrose 0.18% saline</comparator>
    <control>Active</control>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Change in plasma sodium concentration</outcome>
      <timepoint>At 12 to 24 hours.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Proportion of subjects whose plasma sodium concentration changed by &gt;5 mmol/L.</outcome>
      <timepoint>After 12-24 hours.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Rate of change of plasma sodium concentration.</outcome>
      <timepoint>Per hour.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Change in plasma and urinary osmolarity.</outcome>
      <timepoint>After 12 to 24 hours.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Adverse neurological events.</outcome>
      <timepoint>Within 12 to 24 hours.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Frequency of hypoglycaemia.</outcome>
      <timepoint>Within 12 to 24 hours.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Proportion needing fluid resuscitation boluses.</outcome>
      <timepoint>Within 12 to 24 hours.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Net fluid balance.</outcome>
      <timepoint>Within 12 to 24 hours.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Children over 28 days old admitted to PICU who would normally receive IV maintenance fluids for at least 12 hours.</inclusivecriteria>
    <inclusiveminage>28</inclusiveminage>
    <inclusiveminagetype>Days</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>Not stated</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Dysnatraemia (sodium &lt;135mmol/L or &gt;145 mmol/L), glucose &lt;3.5 mmol/L, contra-indications to maintenance fluids (full list available from the chief investigator, includes renal failure, diabetic ketoacidosis, gastroenteritis, raised intra-cranial pressure), previous enrolment, blood tests or IV fluids not indicated.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>After enrolment, subjects are assigned the next available study number and allocated a correspondingly numbered, sealed box containing blinded study fluids and instructions on the infusion rate.</concealment>
    <sequence>Computer-generated random number sequence (randplan command from Stata version 8) in blocks.</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Factorial</assignment>
    <designfeatures />
    <endpoint>Safety/efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 3</phase>
    <anticipatedstartdate>14/03/2005</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>48</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Closed: follow-up continuing</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Women's and Children's Hospital Adelaide. Not sponsored financially.</primarysponsorname>
    <primarysponsoraddress>Women's and Children's Hospital, North Adelaide SA Australia</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname />
      <fundingaddress />
      <fundingcountry />
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>none</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary />
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Women's and Children's Hospital Adelaide</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr Michael Yung</name>
      <address>Women's and Children's Hospital Adelaide
72 Kingwilliam Rd
North Adelaide SA 5006</address>
      <phone>+61 8 81616479</phone>
      <fax>+61 8 81617457</fax>
      <email>michael.yung@cywhs.sa.gov.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Michael Yung</name>
      <address>Women's and Children's Hospital Adelaide
72 Kingwilliam Rd
North Adelaide SA 5006</address>
      <phone>+61 8 81616479</phone>
      <fax>+61 8 81617457</fax>
      <email>yungm@wch.sa.gov.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>